NCT05453682 Hypofractionated IMRT With Concurrent Chemotherapy in Muscle-invasive Bladder Cancer (HIRACUM) Status RECRUITING Phase NA
NCT05429866 Immunological Variables Associated to ICI Toxicity in Cancer Patients Status UNKNOWN Phase PHASE2
NCT05415631 Augmented Bladder Tumor Detection Using Real Time Based Artificial Intelligence Status RECRUITING Phase N/A
NCT05397262 Organ-preservative Therapy of Bladder Cancer With Radiotherapy or Radiochemotherapy Combined With Hyperthermia Status RECRUITING Phase NA
NCT05392634 Multicentral Preventive Antibiotics With Cystectomy Within Enhanced Recovery After Surgery Status UNKNOWN Phase PHASE3
NCT05375903 A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC) Status COMPLETED Phase PHASE1
NCT05366881 cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease Status RECRUITING Phase N/A
NCT05362539 Novel Urine-Based DNA Methylation Biomarkers for Urothelial Bladder Carcinoma Detection in Patients With Hematuria Status COMPLETED Phase NA
NCT05347342 A Diagnostic for the Early Detection of Bladder Cancer Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05344950 Connecting Audio and Radio Sensing Systems to Improve Care at Home Status COMPLETED Phase N/A
NCT05344937 Validation Study of Uromonitor in High Risk Microhematuria Patients Status UNKNOWN Phase N/A
NCT05337189 A Multicenter Clinical Trial of Urine DNA Testing for Bladder Cancer in China Status RECRUITING Phase N/A
NCT05312671 Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer Status RECRUITING Phase PHASE2
NCT05290623 High-power Green-light Laser Endoscopic Submucosal Dissection for Non-muscle-invasive Bladder Cancer Status COMPLETED Phase N/A
NCT05273593 Confocal Laser Endomicroscopy During TransUrethral Resection for Improving BC Diagnosis and Treatment Status COMPLETED Phase NA
NCT05259696 Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01) Status COMPLETED Phase PHASE1/PHASE2
NCT05259397 PF-07225570 Alone or in Combination With an Anti-PD-1 Antibody in Recurrent Non-muscle Invasive Bladder Cancer (NMIBC) Status WITHDRAWN Phase PHASE1